A Phase I clinical trial of PP-001 IV formulation in healthy volunteer
Latest Information Update: 16 May 2021
Price :
$35 *
At a glance
- Drugs KIO 101 (Primary)
- Indications Unspecified
- Focus Therapeutic Use
- 16 May 2021 New trial record
- 12 May 2021 According to EyeGate Pharma media release, company expect to initiate this trial in Q4 2021.